Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

821 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.
Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams B, Lo YR, McClure C, Montaner J, Hirnschall G; ART in Prevention of HIV and TB Research Writing Group. Granich R, et al. Curr HIV Res. 2011 Sep;9(6):446-69. doi: 10.2174/157016211798038597. Curr HIV Res. 2011. PMID: 21999779 Free PMC article. Review.
Adherence to antiretroviral therapy: supervision or support?
Mills EJ, Lester R, Ford N. Mills EJ, et al. Among authors: ford n. Lancet Infect Dis. 2012 Feb;12(2):97-8. doi: 10.1016/S1473-3099(11)70354-1. Lancet Infect Dis. 2012. PMID: 22281134 No abstract available.
Preferred antiretroviral drugs for the next decade of scale up.
Andrieux-Meyer I, Calmy A, Cahn P, Clayden P, Raguin G, Katlama C, Vitoria M, Levin A, Lynch S, Goemaere E, Ford N; Art Sequencing meeting September 22–23, 2011, Geneva, Switzerland. Andrieux-Meyer I, et al. Among authors: ford n. J Int AIDS Soc. 2012 Sep 18;15(2):17986. doi: 10.7448/IAS.15.2.17986. J Int AIDS Soc. 2012. PMID: 23010379 Free PMC article. Review.
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Tang MW, et al. Among authors: ford n. J Infect Dis. 2013 Jun 15;207 Suppl 2(Suppl 2):S70-7. doi: 10.1093/infdis/jit114. J Infect Dis. 2013. PMID: 23687292 Free PMC article.
821 results